InvestorsHub Logo
icon url

jfk

02/22/20 7:57 AM

#2614 RE: john1045 #2613

Chaim has made this into a potential rocket ship based on his conservative use of cash (other than his FAT salary). Most other biotechs would be at 150M share count by now, instead of only 26M outstanding. This gives the stock a massive, massive underpinning for huge gains from here.